Literature DB >> 21575858

Beyond hormone therapy for prostate cancer with PARP inhibitors.

Johann Sebastian de Bono1, Shahneen Sandhu, Gerhardt Attard.   

Abstract

Entities:  

Year:  2011        PMID： 21575858     DOI： 10.1016/j.ccr.2011.05.003

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  8 in total

Review 1.  Prostate cancer in 2011: redefining the therapeutic landscape for CRPC.

Authors:  Carmel Pezaro; Gerhardt Attard
Journal:  Nat Rev Urol       Date:  2012-01-17       Impact factor: 14.432

Review 2.  The role of BRCA1 and BRCA2 in prostate cancer.

Authors:  Elena Castro; Rosalind Eeles
Journal:  Asian J Androl       Date:  2012-04-23       Impact factor: 3.285

3.  PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapy.

Authors:  Michael Fraser; Helen Zhao; Kaisa R Luoto; Cecilia Lundin; Carla Coackley; Norman Chan; Anthony M Joshua; Tarek A Bismar; Andrew Evans; Thomas Helleday; Robert G Bristow
Journal:  Clin Cancer Res       Date:  2011-11-23       Impact factor: 12.531

Review 4.  Tackling the tumor microenvironment: what challenge does it pose to anticancer therapies?

Authors:  Fei Chen; Xinyi Qi; Min Qian; Yue Dai; Yu Sun
Journal:  Protein Cell       Date:  2014-09-05       Impact factor: 14.870

Review 5.  Regulators of homologous recombination repair as novel targets for cancer treatment.

Authors:  Małgorzata Krajewska; Rudolf S N Fehrmann; Elisabeth G E de Vries; Marcel A T M van Vugt
Journal:  Front Genet       Date:  2015-03-20       Impact factor: 4.599

6.  The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells.

Authors:  Francesco Morra; Francesco Merolla; Virginia Napolitano; Gennaro Ilardi; Caterina Miro; Simona Paladino; Stefania Staibano; Aniello Cerrato; Angela Celetti
Journal:  Oncotarget       Date:  2017-05-09

7.  Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer.

Authors:  Michela Masetti; Roberta Carriero; Federica Portale; Giulia Marelli; Nicolò Morina; Marta Pandini; Marta Iovino; Bianca Partini; Marco Erreni; Andrea Ponzetta; Elena Magrini; Piergiuseppe Colombo; Grazia Elefante; Federico Simone Colombo; Joke M M den Haan; Clelia Peano; Javier Cibella; Alberto Termanini; Paolo Kunderfranco; Jolanda Brummelman; Matthew Wai Heng Chung; Massimo Lazzeri; Rodolfo Hurle; Paolo Casale; Enrico Lugli; Ronald A DePinho; Subhankar Mukhopadhyay; Siamon Gordon; Diletta Di Mitri
Journal:  J Exp Med       Date:  2021-12-17       Impact factor: 17.579

8.  Erythropoietin-driven signalling and cell migration mediated by polyADP-ribosylation.

Authors:  D Inbar; M Cohen-Armon; D Neumann
Journal:  Br J Cancer       Date:  2012-09-06       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.